ASLAN Pharmaceuticals Limited (ASLN): Price and Financial Metrics
ASLN Price/Volume Stats
| Current price | $0.60 | 52-week high | $25.44 |
| Prev. close | $0.70 | 52-week low | $0.48 |
| Day low | $0.60 | Volume | 806,300 |
| Day high | $0.70 | Avg. volume | 122,322 |
| 50-day MA | $2.88 | Dividend yield | N/A |
| 200-day MA | $5.14 | Market Cap | 1.23M |
ASLN Stock Price Chart Interactive Chart >
ASLAN Pharmaceuticals Limited (ASLN) Company Bio
ASLAN Pharmaceuticals Pte. Ltd., a biotechnology company, develops immuno-oncology agents and targeted therapies. It offers ASLAN001, a pan-HER inhibitor for solid tumours; and ASLAN002, a cMET inhibitor for solid tumours. The company also inlicenses preclinical and early clinical/development compounds and candidate drugs from pharmaceutical companies focusing on oncology, respiratory, and inflammation diseases; gets proof of concept (PoC) for the partnered compounds in Asia; and outlicenses PoC compounds back to partner for development and launch. It sells its products in Asia and internationally. ASLAN Pharmaceuticals Pte. Ltd. was founded in 2010 and is based in Singapore.
ASLN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -75.96% |
| 1-year | -81.35% |
| 3-year | -98.76% |
| 5-year | -99.37% |
| YTD | -85.63% |
| 2023 | -70.99% |
| 2022 | -67.86% |
| 2021 | -38.80% |
| 2020 | -9.85% |
| 2019 | -43.61% |
Loading social stream, please wait...